Mounting evidence suggests that non-steroidal anti-inflammatory drugs may be useful in reducing the risk of Alzheimer disease. After much study, the mechanism by which these drugs reduce the amyloid deposition associated with the disease is still open to speculation.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease
Journal of Neuroinflammation Open Access 17 August 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Akiyama, H. et al. Inflammation and Alzheimer's disease. Neuroinflammation working group. Neurobiol. Aging 21, 383–421 (2000).
Lim, G.P. et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J. Neurosci. 20, 5709–5714 (2000).
Kisilevsky, R. & Fraser, P. E. Aβ amyloidogenesis: unique, or variation on a systemic theme? Crit. Rev. Biochem. Mol. Biol. 32, 361–404 (1997).
Younkin, S.G. Evidence that Aβ42 is the real culprit in Alzheimer's disease. Ann. Neurol. 37, 287–288 (1995).
Yankner, B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921–932 (1996).
Selkoe, D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399 (Suppl), A23–31 (1999).
Kaufmann, W.E., Andreasson, K.I., Isakson, P.C. & Worley, P.F. Cyclooxygenases and the central nervous system. Prostaglandins 54, 601–624 (1997).
Lehmann, J.M., Lenhard, J.M., Oliver, B.B., Ringold, G.M. & Kliewer, S.A. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272, 3406–3410 (1997).
Mucke, L. et al. High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050–4058 (2000).
Bales, K.R. et al. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nature Genet. 17, 263–264 (1997).
Yan, S.D., Roher, A., Schmidt, A.M. & Stern, D.M. Cellular cofactors for amyloid β-peptide-induced cell stress. Moving from cell culture to in vivo. Am. J. Pathol. 155, 1403–1411 (1999).
Schenk, D. et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173–177 (1999).
Flaris, N.A., Densmore, T.L., Molleston, M.C. & Hickey, W.F. Characterization of microglia and macrophages in the central nervous system of rats: definition of the differential expression of molecules using standard and novel monoclonal antibodies in the normal CNS and in four models of parenchymal reaction. Glia 7, 34–40 (1993).
Hsia, A. et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA 96, 3228–3233 (1999).
Lue, L.-F. et al. Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853–862 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wyss-Coray, T., Mucke, L. Ibuprofen, inflammation and Alzheimer disease. Nat Med 6, 973–974 (2000). https://doi.org/10.1038/79661
Issue Date:
DOI: https://doi.org/10.1038/79661
This article is cited by
-
Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease
Journal of Neuroinflammation (2022)
-
Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target
Molecular Neurobiology (2017)
-
Intranigral LPS Administration Produces Dopamine, Glutathione but not Behavioral Impairment in Comparison to MPTP and 6-OHDA Neurotoxin Models of Parkinson’s Disease
Neurochemical Research (2010)